Aspen said it had agreed to provide capacity required for the manufacture of J&Jâ€™s vaccine candidate, which is still undergoing clinical trials, at its Port Elizabeth facility. Aspen will perform formulation, filling and secondary packaging of the vaccine for supply to J&J, the company said. --Reuters--